Prototypical Stressors

Showing 501 to 525 of 871 Prototypical Stressors

Clear Table Filters
ID Prototypical Stressor Name Associated Chemical(s): Name, CAS-RN, DTXSID Associated AOPs
238 Methoxyfenozide
  • Methoxyfenozide, CAS-RN: 161050-58-4, DTXSID3032628
353 Methoxyflurane
  • Methoxyflurane, CAS-RN: 76-38-0, DTXSID7025556
260: CYP2E1 activation and formation of protein adducts leading to neurodegeneration
38 Methyl methanesulfonate
  • Methyl methanesulfonate, CAS-RN: 66-27-3, DTXSID7020845
None
650 Methyl parathion
  • Methyl parathion, CAS-RN: 298-00-0, DTXSID1020855
39 Methyl-l-N'-nitro-N-nitroguanidine
  • Methylnitronitrosoguanidine, CAS-RN: 70-25-7, DTXSID2020846
None
359 Methylcarbino
None
639 Methyldihydrotestosterone
376: Androgen receptor agonism leading to male-biased sex ratio
40 Methylmercuric(II) chloride
  • Methylmercuric(II) chloride, CAS-RN: 115-09-3, DTXSID5020813
17: Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
218 metofluthrin
  • Metofluthrin, CAS-RN: 240494-70-6, DTXSID4034738
107: Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat
830 Metolachlor
  • Metolachlor, CAS-RN: 51218-45-2, DTXSID4022448
561: Aromatase induction leading to estrogen receptor alpha activation via increased estradiol
855 Metribuzin
  • Metribuzin, CAS-RN: 21087-64-9, DTXSID6024204
567: Binding to plastoquinone B site leading to decreased population growth rate via photosystem II inhibition
574 Metyrapone
  • Metyrapone, CAS-RN: 54-36-4, DTXSID1023314
349: Inhibition of 11β-hydroxylase leading to decresed population trajectory
289 Miconazole
  • Miconazole, CAS-RN: 22916-47-8, DTXSID6023319
None
799 Milrinone
486 minocycline
  • Minocycline, CAS-RN: 10118-90-8, DTXSID1045033
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
676 Mitochondrial ETC inhibitors
None
854 ML385
615: Suppression of Keap1 cysteine oxidation leading to liver inflammation
684 Molinate
  • Molinate, CAS-RN: 2212-67-1, DTXSID6024206
None
64 Mono(2-ethylhexyl) phthalate
457: Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine
569 monobenzyl phthalate
None
692 Montelukast
  • Montelukast, CAS-RN: 158966-92-8, DTXSID9023334
None
222 MPP+
3: Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
403 MS-275
  • MS-275, CAS-RN: 209783-80-2, DTXSID0041068
274: Histone deacetylase inhibition leads to impeded craniofacial development
306 Multi-walled carbon nanotubes
409: Frustrated phagocytosis leads to malignant mesothelioma
847 Muristerone A
342: Ecdysone receptor hyperactivation leading to mortality via mis-timed activation of nuclear receptor cascade